Aleksander Popov

Dr. Aleksander Popov

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2018 in Journal of Separation Science
Verified
Journal Article
Closed access
PDF file
APAleksander Popov
Aleksander Popov
ZBZinaida K. Blinnikova
Zinaida K. Blinnikova
MTMaria P. Tsyurupa
Maria P. Tsyurupa
VDVadim Davankov
Vadim Davankov

1 September 2018 in Polymer Science, Series B
Verified
Journal Article
Closed access
PDF file
APAleksander Popov
Aleksander Popov
ZBZ. K. Blinnikova
Z. K. Blinnikova
MTM. P. Tsyurupa
M. P. Tsyurupa
VDVadim Davankov
Vadim Davankov
With a view to simplifying and reducing the cost of the synthesis of novel selective restricted-access materials based on microporous hypercrosslinked polystyrene for solid-phase extraction, various...

30 October 2023 in Annals of Critical Care
Verified
Journal Article
Open access
PDF file
SRS. I. Rey
S. I. Rey
VKV. V. Kulabukhov
V. V. Kulabukhov
APAleksander Popov
Aleksander Popov
ONO. V. Nikitina
O. V. Nikitina
GBG. A. Berdnikov
G. A. Berdnikov
VPVladimir Pisarev
Vladimir Pisarev
INTRODUCTION: Septic shock is the most serious complication in intensive care that associates with significant mortality. Extracorporeal hemocorrection may improve treatment of patients with septic shock. OBJECTIVE: Evaluation of the effect of hemocorrection with the multimodal adsorbent device Efferon LPS on the dynamics of organ dysfunction and inflammation markers in patients with septic shock. MATERIALS AND METHODS: A multicenter randomized controlled study was conducted in four clinical organizations in the city of Moscow from March 2021 to May 2022. The study included 58 patients (29 men and 29 women) with septic shock. Randomization was performed in a ratio of 2:1 (hemoperfusion: control). Within 24 hours of enrollment in the study, selective hemoperfusion procedures were performed or standard therapy was used. Hemosorption using Efferon LPS was performed twice, with an interval of 24.5 (23.3–26.0) hours. RESULTS: The use of the multimodal selective hemosorbent Efferon LPS significantly reduced the severity of multiple organ failure (MOF) in patients with septic shock from 7 to 3 points on the SOFA scale after 72 hours by improving hemodynamics, respiratory and renal function. In contrast to the control group, in the Efferon LPS group, the levels of CRP, PCT and IL-6 significantly decreased in 72 hours. The severity of MOF significantly correlated with the level of CRP and PCT (Spearman’s r = 0.346 and r = 0.444, respectively). The duration of hospitalization in survived patients was 16.1 days and 30.1 days in the Efferon LPS and control group, respectively (p = 0.032). The need for a renal replacement therapy (RRT) in survivors by the 3rd day was significantly reduced only in the Efferon LPS group — from 73.7 to 33.3 %. CONCLUSIONS: The use of the selective hemosorbent Efferon LPS resulted in significant decreases the hallmarks of systemic inflammation, MOF and requirements for RRT in patients with septic shock.

29 April 2022 in Annals of Critical Care
Verified
Journal Article
Open access
SMSergey V. Masolitin
Sergey V. Masolitin
DPD. N. Protsenko
D. N. Protsenko
ITI. N. Tyurin
I. N. Tyurin
OMO. A. Mamontova
O. A. Mamontova
MMM. A. Magomedov
M. A. Magomedov
APAleksander Popov
Aleksander Popov
INTRODUCTION. Rhabdomyolysis (RM) occurs in 40–60 % of patients with acute poisoning and is accompanied by acute kidney injury (AKI). The most effective method of treatment is the use of extracorporeal detoxification. The most promising is the combined methods of detoxification. OBJECTIVES. Improve outcomes in patients with toxic RM complicated by AKI through early use of selective hemosorption and hemodiafiltration. MATERIALS AND METHODS. The study included 57 patients with toxic genesis RM complicated by AKI. The first group received standard intensive therapy. For the treatment of the second group at the early stage of AKI, hemodiafiltration and selective hemoperfusion were used. We performed a comparative analysis of the dynamics of the main clinical and laboratory parameters, as well as treatment outcomes between groups. RESULTS. The use of selective hemoperfusion and hemodiafiltration at the early stage of AKI allowed to increase the decrease in the level of myoglobin in the blood from 26.3 to 88.0 % and KIM-1 in the urine from 76.1 to 99.0 % during the first week of treatment in the ICU (intensive care unit). Combined detoxification reduced the duration of RRT use from 15 to 6 days, which led to a significant decrease in the level of hospital mortality from 14.3 to 6.9 %, the duration of inpatient treatment from 19.5 to 11 days and the period of stay in the ICU from 11 to 4 days. CONCLUSIONS. Early use of combined extracorporeal detoxification leads to a significant decrease in the level of endogenous intoxication factors, which ultimately made it possible to reduce the duration of treatment in the ICU, hospital and reduce the level of hospital mortality.

8 June 2019 in Journal of Separation Science
Verified
Journal Article
Closed access
PDF file
APAleksander Popov
Aleksander Popov
ZBZinaida K. Blinnikova
Zinaida K. Blinnikova
MTMaria P. Tsyurupa
Maria P. Tsyurupa
VDVadim Davankov
Vadim Davankov

15 June 2022 in Molecules
Verified
Journal Article
Open access
PDF file
Linda NikoshviliLinda Nikoshvili
Linda Nikoshvili
APAleksander Popov
Aleksander Popov
ABAlexey Vladimirovich Bykov
Alexey Vladimirovich Bykov
ASAlexander I. Sidorov
Alexander I. Sidorov
Lioubov Kiwi-MinskerLioubov Kiwi-Minsker
Lioubov Kiwi-Minsker
This work is addressing the selective hydrogenation of alkynols over hybrid catalysts containing Pd-nanoparticles, within newly synthesized hyper-cross-linked polystyrenes (HPS). Alkynols containing C5, C10, and C20 with a terminal triple bond, which are structural analogues or direct semi-products of fragrant substances and fat-soluble vitamins, have been studied. Selective hydrogenation was carried out in a batch mode (ambient hydrogen pressure, at 90 °C, in toluene solvent), using hybrid Pd catalysts with low metal content (less than 0.2 wt.%). The microporous and mesoporous HPS were both synthesized and used as supports in order to address the influence of porosity. Synthesized catalysts were shown to be active and selective: in the case of C5, hydrogenation selectivity to the target product was more than 95%, at close to complete alkynol conversion. Mesoporous catalysts have shown some advantages in hydrogenation of long-chain alkynols.